Simplex Trading’s Biofrontera BFRI Stock Holding History

Simplex Trading’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	–	–	8678
2023 Q2	$0	Buy	+4	New	+$42	﹤0.01%	8965
2022 Q3	–	Sell	-14	Closed	-$383	–	9897
2022 Q2	$0	Buy	+14	New	+$850	﹤0.01%	9955

Other funds holding BFRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CSPIA

Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's BFRI Position: Q3 2023 in Review

Simplex Trading sold out of Biofrontera (BFRI) in Q3 2023, closing a stake of 4 shares.

Simplex Trading first reported a position in BFRI in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2023. 8 funds tracked by Wall St. Rank hold BFRI as of Q3 2023.

Simplex Trading reported no remaining Biofrontera position as of Q3 2023 after selling out during the quarter.
Simplex Trading sold 4 Biofrontera shares in Q3 2023.
Simplex Trading first reported a position in Biofrontera in Q2 2022 and held it in 2 quarters.
Simplex Trading's Biofrontera position peaked at $0 in Q2 2023.
8 funds tracked by Wall St. Rank held Biofrontera as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.